Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
15,03 CNY | -3,28% | -1,76% | +20,14% |
Attività
Numero di dipendenti: 476
Vendite per attività
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Crude Urokinase
43,0
%
| 103 | 42,3 % | 177 | 43,0 % | +71,46% |
Ulinastatin Crude
19,3
%
| 40 | 16,4 % | 80 | 19,3 % | +98,15% |
Senna Granules
15,6
%
| 50 | 20,3 % | 64 | 15,6 % | +29,63% |
New HIV Drug (Enomitide Tablets)
11,9
%
| - | - | 49 | 11,9 % | - |
New HIV Drug (EnovirineTablets)
6,0
%
| 33 | 13,7 % | 25 | 6,0 % | -26,15% |
HIV Diagnostic Reagents
1,8
%
| 12 | 5,0 % | 7 | 1,8 % | -40,95% |
Bacillus Cereus Tablets
1,0
%
| 3 | 1,4 % | 4 | 1,0 % | +19,19% |
Other Crude Human Protein
0,8
%
| 0 | 0,0 % | 3 | 0,8 % | +6.509,67% |
Other Business
0,6
%
| 1 | 0,6 % | 2 | 0,6 % | +69,38% |
Other Generic Drugs
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | -997,00% |
Vendite per regione
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 244 | 100,0 % | 411 | 100,0 % | +68,44% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jie Zhang
CEO | Chief Executive Officer | 54 | - |
Chuanhong Zhu
DFI | Director of Finance/CFO | 53 | 16/09/23 |
He Liang Fu
CHM | Chairman | 63 | 01/01/14 |
Qi Hong
CTO | Chief Tech/Sci/R&D Officer | 61 | 19/01/21 |
Jun Wang
COO | Chief Operating Officer | 50 | 01/01/14 |
Guang Rong Wang
BRD | Director/Board Member | 48 | 01/01/15 |
Wei Xuan Zhou
IRC | Investor Relations Contact | 34 | 01/08/20 |
Yan Liu
SEC | Corporate Secretary | 42 | 14/03/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
He Liang Fu
CHM | Chairman | 63 | 01/01/14 |
Guang Ji Wang
BRD | Director/Board Member | 71 | 09/05/19 |
Xiao Yan Qi
BRD | Director/Board Member | 61 | 10/03/22 |
Guang Rong Wang
BRD | Director/Board Member | 48 | 01/01/15 |
Jun Wang
COO | Chief Operating Officer | 50 | 01/01/14 |
Heng Yu
CHM | Chairman | 44 | 01/12/09 |
Feng Ying He
BRD | Director/Board Member | 41 | 01/12/14 |
Zijian Guo
BRD | Director/Board Member | 63 | 15/09/23 |
Jie Zhang
CEO | Chief Executive Officer | 54 | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 420 782 808 | 185 754 481 ( 44,14 %) | 0 | 44,14 % |
Coordinate società
Jiangsu Aidea Pharmaceutical Co., Ltd.
No.69 New Ganquan West Road Hanjiang District
225008, Yangzhou
+
http://www.aidea.com.cnSettore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,14% | 874 Mln | |
-3,45% | 87,17 Mrd | |
+1,97% | 40,1 Mrd | |
-16,98% | 31,38 Mrd | |
+57,98% | 25,12 Mrd | |
-15,87% | 15,59 Mrd | |
-8,82% | 12 Mrd | |
-41,58% | 11,8 Mrd | |
-15,27% | 11,8 Mrd | |
+6,89% | 8,81 Mrd |
- Borsa valori
- Azioni
- Azione 688488
- Società Jiangsu Aidea Pharmaceutical Co., Ltd.